CN115252472A - Antimicrobial essential oil compositions, products containing the same and methods of making the same - Google Patents
Antimicrobial essential oil compositions, products containing the same and methods of making the same Download PDFInfo
- Publication number
- CN115252472A CN115252472A CN202210059971.8A CN202210059971A CN115252472A CN 115252472 A CN115252472 A CN 115252472A CN 202210059971 A CN202210059971 A CN 202210059971A CN 115252472 A CN115252472 A CN 115252472A
- Authority
- CN
- China
- Prior art keywords
- oil
- antimicrobial essential
- essential oil
- peppermint
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 94
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims description 12
- 239000003921 oil Substances 0.000 claims abstract description 72
- 235000019198 oils Nutrition 0.000 claims abstract description 72
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims abstract description 24
- 235000019477 peppermint oil Nutrition 0.000 claims abstract description 24
- 235000019501 Lemon oil Nutrition 0.000 claims abstract description 17
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000010501 lemon oil Substances 0.000 claims abstract description 17
- 239000005844 Thymol Substances 0.000 claims abstract description 16
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000007746 carvacrol Nutrition 0.000 claims abstract description 16
- 239000010648 geranium oil Substances 0.000 claims abstract description 16
- 235000019717 geranium oil Nutrition 0.000 claims abstract description 16
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000001738 pogostemon cablin oil Substances 0.000 claims abstract description 16
- 229960000790 thymol Drugs 0.000 claims abstract description 16
- 235000004347 Perilla Nutrition 0.000 claims abstract description 14
- 244000124853 Perilla frutescens Species 0.000 claims abstract description 12
- 239000004599 antimicrobial Substances 0.000 claims abstract description 8
- 235000013305 food Nutrition 0.000 claims abstract description 7
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 claims abstract description 6
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 6
- 235000007716 Citrus aurantium Nutrition 0.000 claims abstract description 6
- 240000002319 Citrus sinensis Species 0.000 claims abstract description 6
- 235000005976 Citrus sinensis Nutrition 0.000 claims abstract description 6
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 6
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 6
- 241000018646 Pinus brutia Species 0.000 claims abstract description 6
- 239000010627 cedar oil Substances 0.000 claims abstract description 6
- 239000001748 laurus nobilis l. leaf oil Substances 0.000 claims abstract description 6
- 239000010502 orange oil Substances 0.000 claims abstract description 6
- 239000010668 rosemary oil Substances 0.000 claims abstract description 6
- 229940058206 rosemary oil Drugs 0.000 claims abstract description 6
- 239000010671 sandalwood oil Substances 0.000 claims abstract description 6
- 235000011203 Origanum Nutrition 0.000 claims abstract description 5
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 claims abstract description 5
- 240000000783 Origanum majorana Species 0.000 claims abstract description 3
- 239000001683 mentha spicata herb oil Substances 0.000 claims abstract description 3
- 235000019721 spearmint oil Nutrition 0.000 claims abstract description 3
- 239000000047 product Substances 0.000 claims description 40
- 241000700605 Viruses Species 0.000 claims description 11
- 244000005700 microbiome Species 0.000 claims description 10
- 239000001920 pimenta acris kostel leaf oil terpeneless Substances 0.000 claims description 10
- 235000009508 confectionery Nutrition 0.000 claims description 9
- 230000002147 killing effect Effects 0.000 claims description 9
- 241000205585 Aquilegia canadensis Species 0.000 claims description 5
- 244000183685 Citrus aurantium Species 0.000 claims description 5
- 244000063464 Vitex agnus-castus Species 0.000 claims description 5
- 239000011324 bead Substances 0.000 claims description 5
- 235000009347 chasteberry Nutrition 0.000 claims description 5
- 239000002537 cosmetic Substances 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 230000001681 protective effect Effects 0.000 claims description 5
- 239000004753 textile Substances 0.000 claims description 5
- 244000276331 Citrus maxima Species 0.000 claims description 4
- 235000001759 Citrus maxima Nutrition 0.000 claims description 4
- 241001233305 Xanthisma Species 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 229960000278 theophylline Drugs 0.000 claims description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 241000576429 Forsythia suspensa Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 241001529744 Origanum Species 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 235000015218 chewing gum Nutrition 0.000 claims description 3
- 239000000645 desinfectant Substances 0.000 claims description 3
- 239000003599 detergent Substances 0.000 claims description 3
- 210000004400 mucous membrane Anatomy 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 241000244355 Ligusticum Species 0.000 claims description 2
- 239000002386 air freshener Substances 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 229940112822 chewing gum Drugs 0.000 claims description 2
- 238000007796 conventional method Methods 0.000 claims description 2
- 235000015872 dietary supplement Nutrition 0.000 claims description 2
- 238000004880 explosion Methods 0.000 claims description 2
- 239000003094 microcapsule Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 3
- 241000229722 Perilla <angiosperm> Species 0.000 claims 2
- 235000006297 Origanum majorana Nutrition 0.000 claims 1
- 239000004964 aerogel Substances 0.000 claims 1
- 230000003385 bacteriostatic effect Effects 0.000 claims 1
- 239000009670 cang er zi wan Substances 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 239000001780 majorana hortensis moench (origanum majorana l.) Substances 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 6
- 235000000228 Citrus myrtifolia Nutrition 0.000 abstract description 2
- 235000016646 Citrus taiwanica Nutrition 0.000 abstract description 2
- 240000003791 Citrus myrtifolia Species 0.000 abstract 1
- 240000000560 Citrus x paradisi Species 0.000 abstract 1
- 244000248021 Vitex negundo Species 0.000 abstract 1
- 235000010363 Vitex negundo Nutrition 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 16
- 241000711573 Coronaviridae Species 0.000 description 12
- 230000000120 cytopathologic effect Effects 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 9
- 230000000840 anti-viral effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 4
- 241001678559 COVID-19 virus Species 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000555712 Forsythia Species 0.000 description 2
- 241000112528 Ligusticum striatum Species 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 241001479543 Mentha x piperita Species 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 231100000645 Reed–Muench method Toxicity 0.000 description 2
- 241000315672 SARS coronavirus Species 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000001771 mentha piperita Substances 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 239000000668 oral spray Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 102000053723 Angiotensin-converting enzyme 2 Human genes 0.000 description 1
- 108090000975 Angiotensin-converting enzyme 2 Proteins 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000001528 Coronaviridae Infections Diseases 0.000 description 1
- 231100000491 EC50 Toxicity 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010047482 Viral upper respiratory tract infection Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- -1 body washes Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 239000001693 citrus decumana extract Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000010657 mentha arvensis oil Substances 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000009972 noncorrosive effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229940041678 oral spray Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/06—Coniferophyta [gymnosperms], e.g. cypress
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/22—Lamiaceae or Labiatae [Mint family], e.g. thyme, rosemary, skullcap, selfheal, lavender, perilla, pennyroyal, peppermint or spearmint
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/24—Lauraceae [Laurel family], e.g. laurel, avocado, sassafras, cinnamon or camphor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/36—Rutaceae [Rue family], e.g. lime, orange, lemon, corktree or pricklyash
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/40—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the fats used
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/066—Chewing gum characterised by the composition containing organic or inorganic compounds characterised by the fat used
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D13/00—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
- A41D13/05—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches protecting only a particular body part
- A41D13/11—Protective face masks, e.g. for surgical use, or for use in foul atmospheres
- A41D13/1192—Protective face masks, e.g. for surgical use, or for use in foul atmospheres with antimicrobial agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/01—Deodorant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/01—Deodorant compositions
- A61L9/013—Deodorant compositions containing animal or plant extracts, or vegetable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2101/00—Chemical composition of materials used in disinfecting, sterilising or deodorising
- A61L2101/32—Organic compounds
- A61L2101/34—Hydroxy compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2209/00—Aspects relating to disinfection, sterilisation or deodorisation of air
- A61L2209/20—Method-related aspects
- A61L2209/21—Use of chemical compounds for treating air or the like
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Virology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Pest Control & Pesticides (AREA)
- Physical Education & Sports Medicine (AREA)
Abstract
The invention discloses an antimicrobial essential oil composition, which comprises: carvacrol; thymol; one or more selected from lemon oil, sweet orange oil, citrus aurantium peel oil, lime oil and pomelo peel oil; one or more selected from the group consisting of peppermint oil, spearmint oil, peppermint oil and peppermint oil; one or more selected from laurel leaf oil and marjoram oil; one or more selected from patchouli oil, sandalwood oil and rosemary oil; one or more selected from geranium oil, pine needle oil and cedar wood oil; and optionally one or more selected from perilla oil, chrysanthemum morifolium oil and vitex negundo oil. The invention also discloses a disinfection product, a daily necessity and a food containing the antimicrobial essential oil composition, and a preparation method of the antimicrobial essential oil composition.
Description
Technical Field
The present application relates generally to essential oil compositions, and more particularly to plant essential oil compositions having antimicrobial functionality. The application also relates to products comprising the antimicrobial essential oil composition, and methods of making the antimicrobial essential oil composition.
Background
Many highly pathogenic microbial pathogens cause rapidly-onset and epidemic infectious diseases. Such infectious diseases can spread even in a short time across provinces, countries, or all over the world, i.e., rapidly develop into "pandemics".
During a pandemic period, killing is an important work for epidemic prevention and control. At present, synthetic chemical-based disinfection products (such as ethanol, peracetic acid, chlorine-containing disinfectants, and the like), ultraviolet rays, heat, and the like are commonly used worldwide to inactivate pathogenic microorganisms. However, such disinfection measures have the risks of inconvenient application, limited use, or easy secondary harm and pollution to human bodies and the environment.
Essential oil products based on natural plants have traditionally been used for the treatment of infectious diseases and the control of epidemics for thousands of years. The antimicrobial activity of part of plant essential oils has been demonstrated by a number of studies. The plant essential oil product is harmless to human bodies and environment-friendly while inactivating pathogenic microorganisms, and accords with the trend of green, environment-friendly and sustainable development.
Thus, there is a need to provide plant essential oil products with antimicrobial activity.
We have surprisingly found that by using a combination of a plurality of single essential oils, in combination with specific antimicrobial active ingredients, a biocidal product can be obtained which has good antimicrobial properties and which is harmless to the human body and environmentally friendly.
Disclosure of Invention
To solve the above problems, in an embodiment of the present application, there is provided an antimicrobial essential oil composition, wherein components of the essential oil composition are derived from natural plants, and the combination of these components provides the resulting essential oil composition with good antimicrobial properties.
Embodiments of the present application provide antimicrobial essential oil compositions. The antimicrobial essential oil composition comprises, based on the total weight of the composition: (1) 0.001-80% of one or more selected from carvacrol and thymol; (2) 0.001-99.9% of one or more selected from lemon oil, sweet orange oil, bitter orange peel oil, lime oil and shaddock peel oil; (3) 0.001-99.9% of one or more selected from the group consisting of peppermint oil, spearmint oil, peppermint oil and peppermint oil; (4) 0.001-10% of one or more selected from laurel leaf oil and sweet origanum oil; (5) 0.001-5% of one or more selected from patchouli oil, sandalwood oil and rosemary oil; (6) 0.001-20% of one or more selected from geranium oil, pine needle oil and cedar wood oil; and (7) optionally, 0.001-20% of one or more selected from perilla oil, chrysanthemum morifolium oil and vitex leaf oil.
In another aspect, the antimicrobial essential oil composition comprises (1) 2-80% of one or more selected from carvacrol and thymol; (2) 2-50% of one or more selected from lemon oil, sweet orange oil, bitter orange peel oil, lime oil and shaddock peel oil; (3) 5-40% of one or more selected from peppermint oil, peppermint oil and peppermint oil; (4) 2-20% of one or more selected from laurel leaf oil and sweet origanum oil; (5) 0.1-5% of one or more selected from patchouli oil, sandalwood oil and rosemary oil; (6) 2-20% of one or more selected from geranium oil, pine needle oil and cedar wood oil; and (7) optionally, 2-15% of one or more selected from perilla oil, chrysanthemum morifolium oil and vitex leaf oil.
In one aspect, the antimicrobial essential oil composition further optionally comprises one or more selected from the group consisting of: (8) 0.0001-20% of honeysuckle oil; (9) 0.0001-20% of ligusticum oil; (10) 0.0001-20% of xanthium oil; and (11) 0.0001-20% of weeping forsythia oil.
In another aspect, the antimicrobial essential oil composition comprises: (1) 5% carvacrol and 5% thymol; (2) 35% of lemon oil; (3) 30% of an asian peppermint oil; (4) 10% bay leaf oil; (5) 0.5% of patchouli oil; (6) 5% geranium oil; and (7) 9.5% perilla oil.
In another aspect, the antimicrobial essential oil composition comprises: (1) 0.005% of carvacrol and 0.005% of thymol; (2) 0.1% lemon oil; (3) 99.58% peppermint oil asia; (4) 0.005% of bay leaf oil; (5) 0.25% of patchouli oil; (6) 0.005% geranium oil; and (7) 0.05% perilla oil.
In another aspect, the antimicrobial essential oil composition comprises: (1) 0.005% of carvacrol and 0.005% of thymol; (2) 99.5% lemon oil; (3) 0.25% peppermint oil asian; (4) 0.005% of bay leaf oil; (5) 0.18% of patchouli oil; (6) 0.005% geranium oil; and (7) 0.05% perilla oil.
In another aspect, the antimicrobial essential oil composition comprises: (1) 51.25% carvacrol; (2) 26.25% thymol; (3) 8.75% lemon oil; (4) 7.5% of Asian peppermint oil; (5) 2.5% of bay leaf oil; (6) 0.125% of patchouli oil; (7) 1.25% geranium oil; and (8) 2.375% perilla oil.
In yet another aspect, the antimicrobial essential oil composition comprises: (1) 25% carvacrol and 25% thymol; (2) 2% lemon oil; (3) 10% peppermint oil asia; (4) 20% of bay leaf oil; (5) 0.5% of patchouli oil; (6) 2% geranium oil; (7) 5% of honeysuckle flower oil; (9) 4% of ligusticum wallichii oil; (10) 0.3% of xanthium oil; and (11) 0.2% forsythia oil.
In yet another aspect, the microorganism is selected from the group consisting of bacteria, fungi, viruses, and combinations thereof.
In yet another aspect, the microorganism is a new coronavirus.
Embodiments of the present application also provide a product for reducing or killing microorganisms on one or more of a hard surface, a textile, skin, a mucous membrane, or hair, wherein the product comprises an antimicrobial essential oil composition as any one of described above, and optionally one or more adjuvants.
In one aspect, the product is one or more selected from the group consisting of a disinfecting product, a commodity, a protective product, and a food product. The commodity is one or more selected from the group consisting of cosmetics, home care products, and personal care products, and in another aspect, the commodity is one or more selected from the group consisting of cosmetics, home care products, and personal care products. The sterilizing product comprises one or more of a mask bead, an air freshener, an oral spray, a hand sanitizer, a surface cleaner and a detergent; the food is one or more of chewing gum, bead, gel candy, hard candy, soft candy, beverage, and dietary supplement. The daily necessities can also comprise one or more of a mask bead explosion mask, a civil mask and a medical mask.
Embodiments of the present application also provide a method of preparing the above antimicrobial essential oil composition, the method comprising: all ingredients of the antimicrobial essential oil composition were mixed homogeneously.
In one aspect, the mixing is conducted at ambient temperature and pressure.
The application method also provides a method for preparing the mask from the antimicrobial essential oil composition, which comprises the steps of preparing the essential oil composition into essential oil master batches or essential oil microcapsules, and then preparing the mask according to a conventional method.
Detailed Description
For purposes of the following detailed description, it is to be understood that the application may assume various alternative variations and step sequences, except where expressly specified to the contrary. Moreover, other than in any operating examples, or where otherwise indicated, all numbers expressing, for example, quantities of ingredients used in the specification and claims are to be understood as being modified in all instances by the term "about". Accordingly, unless indicated to the contrary, the numerical parameters set forth in the following specification and attached claims are approximations that may vary depending upon the desired properties to be obtained by the present application. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.
Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the application are approximations, the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective testing measurements.
Moreover, it should be understood that any numerical range recited herein is intended to include all sub-ranges subsumed therein. For example, a range of "1 to 10" is intended to include all sub-ranges between (and including) the recited minimum value of 1 and the recited maximum value of 10, i.e., having a minimum value equal to or greater than 1 and a maximum value of equal to or less than 10.
In this application, the use of the singular includes the plural and plural encompasses singular, unless expressly stated otherwise. In addition, in this application, the use of "or" means "and/or" unless explicitly stated otherwise, even though "and/or" may be explicitly used in some cases. In addition, in this application, the use of "a" or "an" means "at least one" unless explicitly stated otherwise. For example, "a" polymer, "a" composition, and the like refer to one or more of any of these items.
In one embodiment of the present application, an antimicrobial essential oil composition is provided. As used herein, the term "antimicrobial" means that the product used has the activity of reducing/killing microorganisms. In the context of the present application, "microorganism" may include bacteria, fungi, viruses, mycoplasma, and the like, such as, but not limited to, coronaviruses (e.g., SARS-CoV (SARS virus), MERS-CoV (middle east respiratory syndrome virus), SARS-CoV-2 (neocoronavirus), and the like), hepatitis viruses (e.g., hepatitis a, b, c), influenza viruses (e.g., influenza a, b, and avian influenza viruses, and the like), staphylococcus aureus, pneumobacillus, typhoid, candida, molds, mycoplasma pneumoniae, and the like. In a preferred aspect, the virus in the context of the present application may be a new coronavirus.
As used herein, the term "plant essential oil" refers to the generic term for volatile aroma-containing substances obtained from the processing and extraction of natural aromatic plants. Generally, plant essential oils are volatile aromatic substances extracted from parts of plants such as flowers, leaves, roots, seeds, fruits, barks, resins, and hearts by steam distillation, cold pressing, fat absorption, or solvent extraction. Plant essential oils often have specific biological activities, and in particular, some plant essential oils have good antimicrobial activities, such as antibacterial, antifungal and/or antiviral activities, and can be used as effective environmentally friendly antimicrobial agents. The plant essential oil can be divided into single component essential oil and compound essential oil. Wherein, compared with single essential oil, the compound essential oil contains a plurality of effective essential oil components, and can realize significantly better biological activity, such as antimicrobial activity, through the synergistic effect of the components. Compound essential oils are preferably used in the present application.
In one aspect of the present application, an antimicrobial essential oil composition comprises:
(1) One or more selected from carvacrol and thymol, in an amount of 0.0001-99.99%, preferably 2-80%, more preferably 2-60%, and further preferably 6-16%;
(2) One or more selected from lemon oil, sweet orange oil, citrus aurantium peel oil, lime oil and grapefruit peel oil, in an amount of 0.0001 to 99.99%, preferably 2 to 80%, more preferably 2 to 50%, more preferably 10 to 50%, and still more preferably 32 to 38%;
(3) One or more selected from Mentha arvensis oil, mentha piperita oil, and Mentha piperita oil in an amount of 0.0001-99.99%, preferably 2-80%, more preferably 5-40%, further preferably 28-35%;
(4) One or more selected from laurel leaf oil and marjoram oil, in an amount of 0.0001-20%, preferably 2-20%, more preferably 2-18%, more preferably 2-15%, and further preferably 8-12%;
(5) One or more selected from patchouli oil, sandalwood oil and rosemary oil, in an amount of 0.0001-20%, preferably 0.1-18%, more preferably 0.1-5%, even more preferably 0.3-1%;
(6) One or more selected from geranium oil, pine needle oil and cedar wood oil, in an amount of 0.0001-20%, preferably 2-20%, more preferably 2-18%, even more preferably 3-8%,
the above percentages are based on the total weight of the composition.
In one aspect, the antiviral essential oil composition may further optionally comprise (7) one or more selected from perilla oil, chrysanthemum morifolium oil and vitex leaf oil in an amount of 0.0001 to 20%, preferably 2 to 18%, more preferably 2 to 15%, further preferably 8 to 12%, based on the total weight of the composition.
In another aspect, the antiviral essential oil composition may further optionally comprise at least one compound selected from (8) 0.0001-20% of honeysuckle oil; (9) 0.0001-20% of ligusticum wallichii oil; (10) 0.0001-20% of xanthium oil; and (11) 0.0001-20% of one or more of forsythia suspense oil, wherein the percentages are based on the total weight of the composition.
The various ingredients of the antimicrobial essential oil composition in the embodiments of the present application combine to achieve, through synergistic effects, superior antimicrobial properties. For example, when the essential oil composition of the present application is used for in vitro disinfection against new coronaviruses, the killing efficiency of the treatment for 3 and 30 minutes may be higher than 75%, e.g. higher than 80%, 85%, 90%, 95%, 98% or even close to 100%. Without wishing to be bound by any theory, applicants believe that the mechanism by which the essential oil composition kills new coronaviruses may be based, at least in part, on the following facts: the new coronavirus has an envelope structure, belongs to lipophilic (oleophylic) viruses, and is easy to adsorb and enrich by natural plant essential oil theoretically so as to be inactivated. The applicant researches and discovers that after the antiviral plant essential oil is contacted and mixed with the stock solution of the new coronavirus, the new coronavirus can be extracted from the stock solution, and then the new coronavirus can be inactivated quickly and efficiently. There is an active complementation and addition between the various essential oil components selected in this application, achieving unexpected synergy and significantly better antimicrobial properties than single essential oils.
In addition, other benefits may be realized by the essential oil compositions of the present application, including, but not limited to, partial components of the compositions that are capable of blocking the binding of neocoronaviruses to the ACE2 receptor of respiratory epithelial cells (i.e., achieving blocking/protection); some components can promote respiration and improve nasal obstruction caused by early viral upper respiratory tract infection or common cold (i.e. relieving effect). Moreover, the essential oil composition is prepared based on natural plant materials, has fragrant smell, and has the advantages of low irritation, low corrosivity, no toxicity or harm to human bodies, environmental friendliness and the like.
Also disclosed in another embodiment of the present application are products for the microbial disinfection of an environment or human, for example, for reducing or killing microorganisms on one or more of a hard surface, a textile, skin, mucous membrane, or hair. The product comprises the antimicrobial essential oil composition of the present application and optionally one or more adjuvants.
In the context of the present application, the term "hard surface" refers to environmental object surfaces other than textile surfaces and human body surfaces, including but not limited to ceilings, walls, floors/tiles, elevators, stairways, handrails, furniture, tableware, vehicles, etc. commonly used surfaces that are readily accessible in life; the term "textile" includes, but is not limited to, clothing, hats, towels, tablecloths, bedding, and the like; the term "skin" refers to the skin of a human or animal; the term "mucosal" refers to the oral, ocular or rectal mucosa of a human or animal; the term "hair" refers to human hair or body hair, or animal hair or feathers.
In one aspect, the products for microbial disinfection of the environment or human body described herein refer to products that are non-toxic, non-irritating, non-corrosive to the human body, environmentally friendly, and capable of reducing or killing harmful microorganisms in the environment or on the human body, including but not limited to disinfectant products, daily necessities, and foods. For example, the commodity may be a cosmetic, a home care product, and a personal care product, such as a mask, underwear, a pop-up, a tablecloth, and the like. Examples of products for microbial killing of the environment or human body may include, for example, but are not limited to, one or more of furniture cleaners, floor cleaners, kitchen cleaners, toilet cleaners, fabric detergents, disinfecting sprays, oral sprays, toothpastes, mouthwashes, body washes, shampoos, conditioners, skin care products, chewing gums.
In still further embodiments of the present application, there is also provided a method of preparing the antimicrobial essential oil composition as described above, comprising uniformly mixing all the ingredients of the antimicrobial essential oil composition. In one aspect, the mixing is conducted at ambient temperature and pressure.
The present application will be explained in further detail below with reference to examples. However, it will be understood by those skilled in the art that these examples are provided for illustrative purposes only and are not intended to limit the present application.
Examples
Embodiments of the present application will be described in detail below with reference to examples, but those skilled in the art will appreciate that the following examples are only illustrative of the present application and should not be construed as limiting the scope of the present application. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products commercially available. All amounts listed are described in parts by weight based on total weight unless otherwise indicated. This application is not to be construed as limited to the particular embodiments set forth herein.
Examples 1 to 8 and comparative examples 1 to 5
The components were mixed at normal temperature and pressure according to the formulations in tables 1-2 below to prepare the essential oil compositions of examples 1-13, wherein examples 1-5 were the essential oil compositions of the present application and examples 6-13 were the essential oil compositions of the comparative examples.
Test example 1
The essential oil composition of example 1 (labeled as food grade essential oil (FEO)) and the essential oil composition of example 3 (labeled as cosmetic grade essential oil (CEO)) were prepared separately.
Cytotoxicity of FEO and CEO and the effect of inactivating the New coronavirus (SARS-Cov-2) were tested according to the following test methods.
As can be seen from the above results, the essential oil compositions FEO and CEO of the present application have acceptable cytotoxicity and excellent killing effect of new coronavirus.
Test example 2
The essential oil compositions of the examples and comparative examples were evaluated at the cellular level for the effect against the novel coronavirus (SARS-CoV-2) according to the following manner.
Material
Cell: veroE6 cells.
Virus: SARS-CoV-2 (south African variant) with a titer of TCID50 = 10-5Per 100. Mu.L, using a viral titer of 100TCID50。
Essential oil: the compound essential oil is diluted to 6 concentrations by a cell culture medium by adopting a multiple dilution method.
Method
Test for antiviral Properties of drug
(1) The tested drugs are:
(2) Sterile 96-well culture plate, 100. Mu.L of 1X 10 concentration per well5 cells/mL VeroE6 cells, 5% CO at 37 ℃2Culturing for 24 hours;
(3) Adding 100TCID into culture plate experimental group and virus control group50Virus liquid 100 mul/well, 37 deg.C
5% CO2Adsorbing for 2 hours by an incubator;
(4) After 2h, discarding the cell culture solution in the 96-hole culture plate; diluting the tested medicine into each concentration in table 1, wherein each concentration is 3 multiple holes, and adding the liquid medicine into each hole at 100 mu L;
(5) Simultaneously setting a cell control, a blank control (a solvent control), a virus control (a negative control) and a contrast medicine control;
(6) Cells at 37 ℃ 5% CO2Incubating in an incubator for 3 days;
(7) Cytopathic effect (CPE) was observed under an optical microscope and the degree of cytopathic effect was recorded according to the following 6-point scale: "-" no lesions present; "±" means less than 10% cytopathic effect; "+" is about 25% of the cellular pathology; "+ +" indicates about 50% of cellular pathology; "+ + + +" is about 75% of the cells outThe existing pathological changes are as follows: "++++" indicates that more than 75% of the lesions are diseased. The half maximal effective concentration (IC) was calculated using the Reed-Muench method or GraphPad prism5.050). Judging the drug effect standard: concentrations that inhibit viral CPE by 50% are considered effective concentrations.
(8) The experimental conditions are as follows: the above experimental operations are all completed in a BSL-3 laboratory.
Results
1. MTS detection of compound essential oil cytotoxicity:
when the growth state of VeroE6 cells is the best, the cells are digested with 0.02% EDTA and 0.5% trypsin, the cells are adjusted to the required concentration with the growth medium, the cell medium is added into a 96-well cell culture plate at 100. Mu.L/well, and the cells are cultured in a 5% CO2 incubator at 37 ℃ until a dense cell monolayer is obtained. Diluting the compound essential oil with culture medium to different concentrations of 600 μ L/L, 300 μ L/L, 150 μ L/L, 75 μ L/L, 37.5 μ L/L, and 18.75 μ L/L respectively; add to the cell culture plate 100. Mu.L/well. Each dilution was performed in duplicate in 3 wells with normal cell controls. Culturing in a 5% CO2 incubator at 37 deg.C, and detecting cell activity by MTS method, with specific results shown in attached Table 1. Each group of compound essential oil has no toxicity to VeroE6 cells at 300 mu L/L, so that 300 mu L/L is selected as the highest experimental concentration in subsequent experiments.
2. CPE observation: after 72h of virus infection, the normal cell control group has no CPE, the virus control group has obvious CPE, the groups with different essential oil concentrations show different inhibition effects on the CPE, the half effective concentration (IC) is calculated by observing cytopathic effect (CPE) and recording the experimental result by adopting a Reed-Muench method or GraphPad prism5.050) The results are shown in Table 2. All the compound essential oils have antiviral effects, compared with comparative example 1, example 1>5>2>3>4>6>9 are all significantly better than comparative example 1.
Claims (16)
1. An antimicrobial essential oil composition, characterized in that it comprises, based on the total weight of the composition:
(1) 0.001-80% of one or more selected from carvacrol and thymol;
(2) 0.001-99.9% of one or more selected from lemon oil, sweet orange oil, bitter orange peel oil, white lemon oil and shaddock peel oil;
(3) 0.001-99.9% of one or more selected from the group consisting of peppermint oil, spearmint oil, peppermint oil and peppermint oil;
(4) 0.001-10% of one or more selected from laurel leaf oil and sweet origanum oil;
(5) 0.001-5% of one or more selected from patchouli oil, sandalwood oil and rosemary oil;
(6) 0.001-20% of one or more selected from geranium oil, pine needle oil and cedar wood oil; and
(7) Optionally, 0.001-20% of one or more selected from perilla oil, chrysanthemum morifolium oil and vitex leaf oil.
2. An antimicrobial essential oil composition, characterized in that it comprises, based on the total weight of the composition:
(1) 2-80% of one or more selected from carvacrol and thymol;
(2) 2-50% of one or more selected from lemon oil, sweet orange oil, bitter orange peel oil, lime oil and shaddock peel oil;
(3) 5-40% of one or more selected from peppermint oil, peppermint oil and peppermint oil;
(4) 2-20% of one or more selected from laurel leaf oil and sweet marjoram oil;
(5) 0.1-5% of one or more selected from patchouli oil, sandalwood oil and rosemary oil;
(6) 2-20% of one or more selected from geranium oil, pine needle oil and cedar wood oil; and
(7) Optionally, 2-15% of one or more selected from perilla oil, chrysanthemum morifolium oil and vitex leaf oil.
3. The antimicrobial essential oil composition according to claim 1, characterized in that the antimicrobial essential oil composition further optionally comprises one or more selected from the group consisting of:
(8) 0.0001-20% of honeysuckle flower oil;
(9) 0.0001-20% of rhizoma Ligustici Chuanxiong oil;
(10) 0.0001-20% of fructus Xanthii oil; and
(11) 0.0001-20% of weeping forsythia oil.
4. Antimicrobial essential oil composition according to claim 1, characterized in that it comprises:
(1) 5% carvacrol and 5% thymol;
(2) 35% lemon oil;
(3) 30% asian dementholized oil;
(4) 10% bay leaf oil;
(5) 0.5% of patchouli oil;
(6) 5% geranium oil; and
(7) 9.5% of perilla oil.
5. Antimicrobial essential oil composition according to claim 1, characterized in that it comprises:
(1) 0.005% carvacrol and 0.005% thymol;
(2) 0.1% lemon oil;
(3) 99.58% asian peppermint oil;
(4) 0.005% bay leaf oil;
(5) 0.25% patchouli oil;
(6) 0.005% geranium oil; and
(7) Perilla oil 0.05%.
6. Antimicrobial essential oil composition according to claim 1, characterized in that it comprises:
(1) 0.005% carvacrol and 0.005% thymol;
(2) 99.5% lemon oil;
(3) 0.25% peppermint oil asia;
(4) 0.005% bay leaf oil;
(5) 0.18% patchouli oil;
(6) 0.005% geranium oil; and
(7) Perilla oil 0.05%.
7. Antimicrobial essential oil composition according to claim 1, characterized in that it comprises:
(1) 51.25% carvacrol;
(2) 26.25% thymol;
(3) 8.75% lemon oil;
(4) 7.5% peppermint oil asia;
(5) 2.5% bay leaf oil;
(6) 0.125% patchouli oil;
(7) 1.25% geranium oil; and
(8) 2.375% perilla oil.
8. The antimicrobial essential oil composition of claim 3, characterized in that the antimicrobial essential oil composition comprises:
(1) 25% carvacrol and 25% thymol;
(2) 2% lemon oil;
(3) 10% peppermint oil asia;
(4) 20% bay leaf oil;
(5) 0.5% patchouli oil;
(6) 2% geranium oil;
(7) 5% of honeysuckle oil;
(9) 4% of ligusticum oil;
(10) 0.3% xanthium oil; and
(11) 0.2% of weeping forsythia oil.
9. Antimicrobial essential oil composition according to any one of claims 1 to 8, characterized in that the microorganism is selected from the group consisting of bacteria, fungi, viruses and combinations thereof.
10. Antimicrobial essential oil composition according to any one of claims 1 to 8, characterized in that the microorganism is a neocoronavirus.
11. A product for reducing or killing microorganisms on one or more of a hard surface, a textile, skin, a mucous membrane or hair, characterized in that the product comprises the antimicrobial essential oil composition according to any one of claims 1-8 and optionally one or more adjuvants.
12. The product of claim 11, characterized in that the product is one or more selected from the group consisting of a disinfectant product, a commodity, a protective product, and a food product.
13. The product of claim 12, wherein the consumer product is one or more selected from the group consisting of a cosmetic product, a household care product, and a personal care product, wherein the consumer product comprises one or more of a mask pop, an air freshener, a mouth spray, a hand sanitizer, an aerogel, a bacteriostatic spray, a sanitary wipe, a surface cleaner, and a detergent; the food is one or more of chewing gum, popping beads, gel candy, hard candy, soft candy, beverage and dietary supplement; the protective articles comprise one or more of a mask bead explosion mask, a civil mask, a medical mask, protective gloves and protective clothes.
14. A process for preparing the antimicrobial essential oil composition of any one of claims 1-8, comprising: all ingredients of the antimicrobial essential oil composition are mixed homogeneously.
15. The method of claim 14, characterized in that the mixing is carried out at ambient temperature and pressure.
16. A method of manufacturing a mask according to claim 13 comprising preparing the antimicrobial essential oil composition of any one of claims 1 to 8 into essential oil concentrate or essential oil microcapsule, and manufacturing the mask according to a conventional method.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2022/075389 WO2022068977A2 (en) | 2021-04-30 | 2022-02-07 | Antimicrobial essential oil composition, product comprising same, and preparation method for product thereof |
CN202280000139.9A CN114929252B (en) | 2021-04-30 | 2022-02-07 | Antimicrobial essential oil composition, article comprising same and method of making article |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2021104820921 | 2021-04-30 | ||
CN202110482092 | 2021-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115252472A true CN115252472A (en) | 2022-11-01 |
Family
ID=83758996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210059971.8A Pending CN115252472A (en) | 2021-04-30 | 2022-01-19 | Antimicrobial essential oil compositions, products containing the same and methods of making the same |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115252472A (en) |
-
2022
- 2022-01-19 CN CN202210059971.8A patent/CN115252472A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104873432B (en) | Handguard type Washing free gel for disinfection and preparation method thereof | |
JP5092145B2 (en) | Anti-norovirus agent and composition containing the same | |
JP5670201B2 (en) | Antiviral agent and antiviral composition against envelope virus belonging to influenza A virus genus | |
KR20160079473A (en) | Preparation method of cleaning or disinfecting composition having antiviral activity by containing green tea extract as active component | |
KR20170021573A (en) | External use sanitizers containing hinoki cypress leaf extract and lemon leaf extract and manufacturing method of the same | |
CN110478293A (en) | A kind of disposable disinfection hand cleanser and preparation method thereof | |
KR102292707B1 (en) | Antiviral composition comprising natural substance-derived substance and acidic hypochlorous acid | |
CN114929252B (en) | Antimicrobial essential oil composition, article comprising same and method of making article | |
WO2010094151A1 (en) | Disinfectant making air fresh and preparation method and use thereof | |
KR102213514B1 (en) | Natural composition for inhibiting corona virus activity | |
KR20160079459A (en) | Cleaning or disinfecting composition having antiviral activity by containing green tea extract as active component | |
CN112641699A (en) | Antibacterial wet tissue and preparation method thereof | |
CN115252472A (en) | Antimicrobial essential oil compositions, products containing the same and methods of making the same | |
KR102252009B1 (en) | Antiviral or antibacterial composition containing extracts of Torreya nucifera leaf | |
CN1670166A (en) | Moutan bark cleaning products | |
KR20120025740A (en) | Natural anti-bacterial composition and spray solution containing the same | |
CN1670160A (en) | Phellodendron bark cleaning products | |
CN1670154A (en) | Wild chrysanthemum flower cleaning products | |
Chandravanshi et al. | Formulation of herbal hand sanitizer from Indian herbs | |
KR102327236B1 (en) | Compositions for Anti-microbial and Deodorization Effect Comprising Complex Extract of Plants | |
CN112891477A (en) | Preparation method and application of antibacterial and antiviral aromatic armour essential oil composition | |
KR20110028745A (en) | Antibacterial detergent composition | |
KR102344582B1 (en) | Composition for antiviral comprising natural extracts | |
KR102600013B1 (en) | Antibacterial functional lotion composition | |
Al-Bayaty et al. | Effect of mouthwash extracted from Miswak (Salvadora Persica) on periodontal pathogenic bacteria an in-vitro study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication |